Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
OncoTargets and Therapy. 2009;161 
Anti-epidermal growth factor receptor (anti-EGFR) antibody conjugated fluorescent nanoparticles probe for breast cancer imaging
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2009;74(2):410-414
Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
Therapeutics and Clinical Risk Management. 2008;Volume 4:1221-1227
Recent Data with Anti—Epidermal Growth Factor Receptor Antibodies and Irinotecan in Colon Cancer
Clinical Colorectal Cancer. 2005;5:S81-S88
Epidermal growth factor expression in human colon and colon carcinomas: Anti-sense epidermal growth factor receptor rna down-regulates the proliferation of human colon cancer cells
International Journal of Cancer. 1995;62(6):661-667
Synergistic effects of chemotherapy and anti-epidermal growth factor receptor (EGFr) monoclonal antibodies (MAb)
Lung Cancer. 1991;7:17
Preparation of epidermal growth factor (EGF) conjugated iron oxide nanoparticles and their internalization into colon cancer cells
Journal of Magnetism and Magnetic Materials. 2010;322(15):2244-2250
The Role of Anti-Epidermal Growth Factor Receptor Antibodies in Head and Neck Cancer
Annals of Oncology. 2012;23:xi57
Epidermal growth factor/epidermal growth factor receptor signaling axis is a significant regulator of the proteasome expression and activity in colon cancer cells
ScienceOpen Research. 2014;
First-Line Use of Anti–Epidermal Growth Factor Receptor Monoclonal Antibodies in Metastatic Colorectal Cancer
Clinical Colorectal Cancer. 2007;6:S42-S46